| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13154391 | 2013-02-07 | ||
| PCT/EP2014/000337WO2014121942A1 (en) | 2013-02-07 | 2014-02-07 | Macrocyclic pyridazinone derivatives |
| Publication Number | Publication Date |
|---|---|
| SG11201506099XAtrue SG11201506099XA (en) | 2015-09-29 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506099XASG11201506099XA (en) | 2013-02-07 | 2014-02-07 | Macrocyclic pyridazinone derivatives |
| Country | Link |
|---|---|
| US (2) | US9550794B2 (en) |
| EP (1) | EP2953952B1 (en) |
| JP (1) | JP6267729B2 (en) |
| KR (1) | KR102216812B1 (en) |
| CN (1) | CN105008371B (en) |
| AU (1) | AU2014214254B2 (en) |
| BR (1) | BR112015018751A2 (en) |
| CA (1) | CA2900442C (en) |
| DK (1) | DK2953952T3 (en) |
| ES (1) | ES2639717T3 (en) |
| HR (1) | HRP20171302T1 (en) |
| HU (1) | HUE035919T2 (en) |
| IL (1) | IL240291B (en) |
| LT (1) | LT2953952T (en) |
| MX (1) | MX367897B (en) |
| PL (1) | PL2953952T3 (en) |
| PT (1) | PT2953952T (en) |
| RS (1) | RS56269B1 (en) |
| RU (1) | RU2660435C2 (en) |
| SG (1) | SG11201506099XA (en) |
| SI (1) | SI2953952T1 (en) |
| WO (1) | WO2014121942A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS56331B1 (en)* | 2013-02-07 | 2017-12-29 | Merck Patent Gmbh | Pyridazinone-amides derivatives |
| US9708324B2 (en) | 2015-02-05 | 2017-07-18 | Merck Patent Gmbh | Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof |
| CA2970550C (en)* | 2015-02-06 | 2023-09-19 | Merck Patent Gmbh | Pyridazinone macrocycles as irak inhibitors and uses thereof |
| EA039043B1 (en) | 2015-04-22 | 2021-11-25 | Райджел Фармасьютикалз, Инк. | Pyrazole compounds and method for making and using the compounds |
| JOP20180011A1 (en) | 2017-02-16 | 2019-01-30 | Gilead Sciences Inc | Perulo derivatives [1, 2-b] pyridazine |
| MX2020003190A (en) | 2017-09-22 | 2020-11-11 | Kymera Therapeutics Inc | Protein degraders and uses thereof. |
| US11358948B2 (en) | 2017-09-22 | 2022-06-14 | Kymera Therapeutics, Inc. | CRBN ligands and uses thereof |
| WO2019111218A1 (en) | 2017-12-08 | 2019-06-13 | Cadila Healthcare Limited | Novel heterocyclic compounds as irak4 inhibitors |
| IL315310A (en) | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | IRAK joints and used in them |
| EP3737666A4 (en) | 2018-01-12 | 2022-01-05 | Kymera Therapeutics, Inc. | Protein degraders and uses thereof |
| WO2019140387A1 (en) | 2018-01-12 | 2019-07-18 | Kymera Therapeutics, Inc. | Crbn ligands and uses thereof |
| WO2019236625A1 (en) | 2018-06-04 | 2019-12-12 | Ohio State Innovation Foundation | Eaat2 activators and methods of using thereof |
| US11292792B2 (en) | 2018-07-06 | 2022-04-05 | Kymera Therapeutics, Inc. | Tricyclic CRBN ligands and uses thereof |
| TWI721483B (en) | 2018-07-13 | 2021-03-11 | 美商基利科學股份有限公司 | Pyrrolo[1,2-b]pyridazine derivatives |
| BR112021010484A2 (en) | 2018-11-30 | 2021-08-24 | Kymera Therapeutics, Inc. | Irak degraders and their uses |
| JP7590996B2 (en)* | 2019-06-24 | 2024-11-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Novel macrocyclic compounds and derivatives as EGFR inhibitors |
| JP2022545542A (en) | 2019-08-30 | 2022-10-27 | ライジェル ファーマシューティカルズ， インコーポレイテッド | Pyrazole compounds, formulations thereof and methods of using the compounds and/or formulations |
| CA3159561A1 (en) | 2019-11-04 | 2021-05-14 | Revolution Medicines, Inc. | Ras inhibitors |
| BR112022011651A2 (en) | 2019-12-17 | 2022-08-23 | Kymera Therapeutics Inc | IRAK DEGRADATORS AND USES THEREOF |
| EP4076524A4 (en) | 2019-12-17 | 2023-11-29 | Kymera Therapeutics, Inc. | IRAQ DEGRADERS AND USES THEREOF |
| TW202210483A (en) | 2020-06-03 | 2022-03-16 | 美商凱麥拉醫療公司 | Crystalline forms of irak degraders |
| CN116457358A (en) | 2020-09-15 | 2023-07-18 | 锐新医药公司 | Indole derivatives as RAS inhibitors for the treatment of cancer |
| WO2022117051A1 (en)* | 2020-12-03 | 2022-06-09 | 北京鞍石生物科技有限责任公司 | Macrocyclic compound, preparation method therefor and use thereof |
| AU2021413371A1 (en) | 2020-12-30 | 2023-07-13 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| MX2023009527A (en) | 2021-02-15 | 2023-08-24 | Kymera Therapeutics Inc | Irak4 degraders and uses thereof. |
| US12357623B2 (en) | 2021-03-03 | 2025-07-15 | Rigel Pharmaceuticals, Inc. | Method for treating a disease or condition using a pyrazole compound or formulation thereof |
| WO2022235870A1 (en) | 2021-05-05 | 2022-11-10 | Revolution Medicines, Inc. | Ras inhibitors for the treatment of cancer |
| PH12023500023A1 (en) | 2021-05-07 | 2024-03-11 | Kymera Therapeutics Inc | Cdk2 degraders and uses thereof |
| AR127308A1 (en) | 2021-10-08 | 2024-01-10 | Revolution Medicines Inc | RAS INHIBITORS |
| JP2024540080A (en) | 2021-10-29 | 2024-10-31 | カイメラ セラピューティクス， インコーポレイテッド | IRAK4 degraders and their synthesis |
| TW202339738A (en) | 2022-01-31 | 2023-10-16 | 美商凱麥拉醫療公司 | Irak degraders and uses thereof |
| TW202346291A (en) | 2022-03-23 | 2023-12-01 | 美商雷傑製藥公司 | Pyrimid-2-yl-pyrazole compounds as irak inhibitors |
| EP4615850A1 (en)* | 2022-11-10 | 2025-09-17 | BeiGene Switzerland GmbH | Compounds for the degradation of egfr kinase |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2367422T3 (en)* | 2001-10-09 | 2011-11-03 | Amgen Inc. | IMIDAZOL DERIVATIVES AS ANTI-INFLAMMATORY AGENTS. |
| WO2004083188A1 (en)* | 2003-03-18 | 2004-09-30 | Kowa Co., Ltd. | Water-soluble phenylpyridazine derivative and medicine containing the same |
| EP2061786A2 (en)* | 2006-09-07 | 2009-05-27 | Biogen Idec MA Inc. | Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| MX2011002470A (en)* | 2008-09-08 | 2011-04-05 | Merck Patent Gmbh | Macrocyclics pyrimidines as aurora kinase inhibitors. |
| RS55165B1 (en)* | 2010-12-20 | 2017-01-31 | Merck Serono Sa | Indazolyl triazole derivatives as irak inhibitors |
| Publication number | Publication date |
|---|---|
| US20170143713A1 (en) | 2017-05-25 |
| JP2016507539A (en) | 2016-03-10 |
| IL240291B (en) | 2019-06-30 |
| HUE035919T2 (en) | 2018-05-28 |
| AU2014214254B2 (en) | 2018-03-29 |
| US20150376206A1 (en) | 2015-12-31 |
| KR20150118980A (en) | 2015-10-23 |
| RS56269B1 (en) | 2017-11-30 |
| PT2953952T (en) | 2017-09-11 |
| HRP20171302T1 (en) | 2017-10-20 |
| RU2660435C2 (en) | 2018-07-06 |
| PL2953952T3 (en) | 2017-10-31 |
| SI2953952T1 (en) | 2017-10-30 |
| KR102216812B1 (en) | 2021-02-18 |
| AU2014214254A1 (en) | 2015-09-17 |
| RU2015137756A (en) | 2017-03-13 |
| DK2953952T3 (en) | 2017-08-28 |
| HK1216645A1 (en) | 2016-11-25 |
| CN105008371A (en) | 2015-10-28 |
| ES2639717T3 (en) | 2017-10-30 |
| US10064861B2 (en) | 2018-09-04 |
| MX367897B (en) | 2019-09-11 |
| US9550794B2 (en) | 2017-01-24 |
| CA2900442A1 (en) | 2014-08-14 |
| CA2900442C (en) | 2021-09-21 |
| IL240291A0 (en) | 2015-09-24 |
| MX2015010128A (en) | 2017-07-26 |
| JP6267729B2 (en) | 2018-01-24 |
| BR112015018751A2 (en) | 2017-07-18 |
| WO2014121942A1 (en) | 2014-08-14 |
| LT2953952T (en) | 2017-08-25 |
| CN105008371B (en) | 2018-09-18 |
| EP2953952B1 (en) | 2017-06-07 |
| EP2953952A1 (en) | 2015-12-16 |
| Publication | Publication Date | Title |
|---|---|---|
| SG11201506099XA (en) | Macrocyclic pyridazinone derivatives | |
| IL240863B (en) | Amatoxin derivatives | |
| SG11201506100XA (en) | Pyridazinone-amides derivatives | |
| IL244609A0 (en) | 4-azaindole derivatives | |
| IL243249A0 (en) | Diazacarbazole derivatives as tau-pet-ligands | |
| ZA201601333B (en) | Oxoquinazolinyl-butanamide derivatives | |
| ZA201507657B (en) | Pyridin-4-yl derivatives | |
| SG11201605189YA (en) | Imidazopyrazinone derivatives | |
| GB201314960D0 (en) | Heterocyclic derivatives | |
| GB201300306D0 (en) | Heterocyclic derivatives | |
| GB201303685D0 (en) | Cyclosporin derivatives | |
| GB201303681D0 (en) | Cyclosporin derivatives | |
| GB201300649D0 (en) | Cyclization | |
| GB201306476D0 (en) | Squared |